SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015637
Filing Date
2021-11-12
Accepted
2021-11-12 07:10:43
Documents
14
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20211112x8k.htm   iXBRL 8-K 38419
2 EX-99.1 bpth-20211112xex99d1.htm EX-99.1 19043
3 GRAPHIC bpth-20211112xex99d1001.jpg GRAPHIC 5618
  Complete submission text file 0001558370-21-015637.txt   191353

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20211112.xsd EX-101.SCH 3006
5 EX-101.LAB bpth-20211112_lab.xml EX-101.LAB 16080
6 EX-101.PRE bpth-20211112_pre.xml EX-101.PRE 10280
7 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20211112x8k_htm.xml XML 4921
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 211399512
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences